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Purpose of the review 
Ventilator-associated pneumonia (VAP) remains a frequent and severe complication in 
endotracheal intubated patients. Strict adherence to preventive measures reduces the risk of 
VAP. The objective of this paper is to review what has come forward in recent years in the 
non-pharmacologically prevention of VAP.  
 
Recent findings  
It seems advantageous to implement care bundles rather than single prevention measures. 
A solid basis of knowledge seems necessary to facilitate implementation and maintain a high 
adherence level. Continuous educational efforts have a beneficial effect on attitude towards 
VAP. Intermittent subglottic secretions drainage, continuous lateral rotation therapy, and 
poly-urethane cuffed endotracheal tubes decrease the risk of pneumonia. In an in vitro setting, 
an endotracheal tube with a tapered shaped cuff appear to better prevent fluid leakage 
compared to cylindrical poly-urethane or polyvinylchloride cuffed tubes. Cuff pressure 
control by means of an automatic device and multimodality chest physiotherapy need further 
investigation, as does some aspects of oral hygiene. 
  
Summary 
New devices and strategies are developed to prevent VAP. Some of these are promising but 
need further study. Besides this, more attention goes to factors that might facilitate the 
implementation process and the challenge to achieve high adherence rates. 
 
Key words 
Ventilator-associated pneumonia, prevention, endotracheal tube, bundle 
 
 
 
Abbreviations 
VAP ventilator-associated pneumonia 
ICU intensive care unit 
PU poly-urethane 
PVC polyvinylchloride 
CI confidence interval 
OR odds ratio
Introduction 
Despite many efforts taken in the field of prevention, healthcare-associated pneumonia remain 
among the most frequent complications associated with intensive care unit (ICU) admission. 
In a large European study including nearly 120,000 ICU patients, Lambert et al. found 
healthcare-associated pneumonia to be associated with an excess risk of death (adjusted 
hazard ratio) ranging from 1.7 (95% confidence interval [CI] 1.4–1.9) for methicillin-
susceptible Staphylococcus aureus to 3.5 (2.9–4.2) for ceftazidime resistant Pseudomonas 
aeruginosa [1]. Most of these are ventilator-associated pneumonia (VAP). Several studies 
found VAP to be associated with a significant excess in morbidity and mortality, as well as a 
substantial economic burden [2, 3]. In order to limit the deleterious effect of severe infections, 
prevention remains the first step to take [4]. Unfortunately, VAP is not a rare complication. 
Recent surveillance data from a large initiative in which 173 ICUs from different continents 
were involved, estimated the pooled mean of VAP to be 13.6 per 1000 mechanical ventilation 
days (95% confidence interval: 13.3–14.0) [5]. Therefore in many infection prevention 
programs special emphasis is given to VAP. Many preventive measures can be taken to 
reduce the risk of VAP, either as a single measure or combined with others. Yet, the strength 
of evidence about some measures is often a matter of discussion as guidelines developed by 
distinct societies are frequently conflicting [6]. Also concerning strategies to facilitate 
implementation and adherence there exist no consensus [7]. The value of several newly 
developed measures remains controversial or need at least additional conformation in either 
larger clinical trials [8]. The objective of this review is to summarize which elements in the 
non-pharmacological prevention of VAP have come to the front in the past year. 
 
Awareness, knowledge, and a positive attitude: prerequisites for successful 
implementation. In general, teams tend to be conservative in nature and often change will 
provoke resistance. Therefore it is essential to prepare the team for the upcoming 
modifications in policy. In order to facilitate the process of implementation and optimize 
adherence rates, the following elements should be taken into account [9]. First, the team must 
be aware of the problem and perceive VAP as a real problem that threatens the prognosis of 
patients. Second, basic knowledge of the pathogenesis is essential to understand the 
underlying concept of some preventive measures. Lack of profound insights frequently are the 
main reason  for poor compliance. Third, knowledge of infection prevention in general, and 
VAP prevention in particular, are pivotal to have the prevention protocol adopted with at least 
some assurance of a long-term favorable effect. Recent data indicate that there exist a 
substantial lack of knowledge among ICU clinicians concerning VAP prevention [10-12]. 
Based on a questionnaire Labeau et al. evaluated the knowledge about evidence-based 
guidelines for VAP prevention of 3329 ICU nurses from 22 European countries [13]. Overall, 
the results were disappointing with an average score of 45%.  
Targeted education seems to be the key to increase awareness of the problem and the 
necessary knowledge to tackle it. As publication and distribution of guidelines on itself seems 
not to result in improved implementation, an interactive web-based ‘crash course’ in infection 
prevention is developed (http://www.evidenceproject.org/). The interactive course design 
might be helpful to more easily adopt and maintain knowledge about issues such as VAP 
prevention. To which extent this learning module is effective, is still a matter of study. An 
additional main beneficial effect of continuous education is a change in attitude towards the 
problem. The team should perceive VAP as a challenge in which it is possible to succeed, and 
not as a obstacle that simply cannot be prevented in some patients. There exists a relationship 
between hand hygiene compliance of nurses and a supportive, enthusiastic attitude in terms of 
self-efficacy [14]. Recent data by Bouadma L et al. demonstrated that a multifaceted 
educational program focused on VAP prevention gradually changed behavior over a one year 
period [15]. Positive perception was significantly associated with cognitive factors predicting 
behavior. Indeed, analogue with the educational program, these investigators demonstrated 
significantly increased compliance rates with an 8-item prevention program [16], as well as a 
decrease in VAP incidence by 43% (from 22.6 to 13.1 VAP per 1000 mechanical ventilation 
days)[17].  
 
Intermittent subglottic secretions drainage 
The most important element in the pathogenesis of VAP is micro-aspiration of subglottic 
secretions. Subglottic secretions drainage (SSD) by use of an endotracheal tube with a 
separate dorsal lumen that opens directly above the cuff, has been developed to avoid micro-
aspiration. SSD can be performed either continuous or intermittent. However, concerns about 
injuries at the tracheal mucosa have been raised by the use of continuous SSD. Therefore 
Lacherade et al. performed a multicenter trial including 333 intubated patients expected to 
require mechanical ventilation >48 hours in which intermittent SSD was compared with a 
control group without SSD [18]. In the experimental group subglottic secretions were 
aspirated with 10 mL syringe each hour. Microbiologically confirmed VAP occurred in 
14.8% of patients in the experimental group and 25.6% in the control group (p=0.02), which 
corresponds with a relative risk reduction of 42.2% (95% confidence interval: 10.4 – 63.1%). 
This favorable effect was valid for early and late-onset VAP (using a 5-day threshold).  
 
Endotracheal tube cuff material and cuff shape 
Ultrathin poly-urethane (PU) cuffs have been developed to minimize the channel size within 
folds of an inflated cuff. In a randomized controlled trial by Poelaert et al., PU cuffed 
endotracheal tubes resulted in a significant reduction of early post-operative pneumonia in 
post-cardiac surgery patients (adjusted odds ratio 0.31, 95% confidence interval: 0.13 – 0.77) 
compared to conventional polyvinylchloride (PVC) cuffed endotracheal tubes [19]. Miller et 
al. evaluated the use of PU cuffed endotracheal tubes for the prevention of VAP in a 
retrospective, interrupted time-series analysis [20]. The rate of VAP was compared before, 
during and after the replacement of a conventional PVC cuffed tube by a PU cuffed tube. 
VAP rates decreased from 5.3/1000 ventilator days before the use of the PU cuffed tube to 
2.8/1000 ventilator days during the intervention (p=0.013). During the first three months after 
the return to PVC cuffed tubes, the rate of VAP was 3.5/1000 ventilator days. In a regression 
analysis which controlled for confounding variables, the use of a PU cuffed tube was 
associated with a significant decrease in the risk of VAP (incidence risk ratio: 0.565, 95% CI 
0.335-0.935). In a study by Lorente et al. PU cuffed endotracheal tubes were successfully 
combined with SSD [21]. Compared to conventional PVC cuffed endotracheal tubes without 
SSD, this tube demonstrated a significant reduction in early (3.6% vs. 10.7%; p=0.02) and 
late-onset VAP (9.5% vs. 26.7%; p=0.01). Because of the combination of both prevention 
aspects, it is uncertain which concept contributed the most in the reduction of VAP risk. 
Anyhow, the future of VAP prevention by means of innovative devices, lays probably by the 
combination of characteristics which all comprise a VAP prevention potential. 
Another innovation developed to avoid micro-aspiration, concerns the cuff shape. 
Conventional endotracheal tubes have a cylindrical shaped cuff. As a consequence an inflated 
cuff will always have folds by which leakage is possible. Recently a nendotracheal tube with 
a tapered shaped cuff was developed. The promise of this cuff is that it better accommodates 
natural variations in the size of the tracheal. As such, at least at one point, the taper shaped 
cuff seals the trachea without fold formation. In an in vitro study by Dave et al. demonstrated 
that endotracheal tubes with taper shaped cuffs have superior sealing capacity compared to 
cylindrical shaped cuffs and are equally effective as cylindrical shaped PU cuffed 
endotracheal tubes [22]. However, the study design included the use of different sizes of 
artificial tracheas (16, 20, and 22 mm internal diameter) and in larger tracheal diameters, the 
tapered shape cuff was more efficient in the prevention of fluid leakage compared with 
cylindrical shaped PU cuffs. To which extent the endotracheal tube with a tapered shaped cuff 
results in reduced VAP rates remains to be demonstrated. 
 
Cuff pressure monitoring 
No cuff seals unless it is sufficiently inflated. On the other hand, excessive cuff pressure 
(above 30 cm H2O) impose tracheal damage. A recent survey by Labeau et al. evaluated both 
daily practice and knowledge about cuff pressure management in 591 ICU nurses [23]. 
Respondents were well aware of the importance of optimal cuff pressures and of the 
consequences of either insufficient or excessive pressures. Nevertheless, in the absence of a 
specific indication (e.g. audible leakage), 53% checks pressure only every 8 hours and 
frequently this is done by means of finger palpation of the pilot balloon. Recently Liu et al. 
showed that cuff pressure estimates by finger palpation results in excessive cuff pressure and 
that monitoring the cuff with a manometer results in fewer post-intubation complications [24]. 
In order to guarantee optimal cuff pressure monitoring and regulation an automatic device has 
been developed. This device proved to decrease the risk of insufficient cuff pressure (defined 
as <20 cm H2O), but no decrease in VAP was observed [25].  
 
Continuous lateral rotation therapy 
The value of kinetic beds to reduce the risk of VAP have been confirmed earlier but because 
of the high cost associated with this approach and the lack of benefits in terms of survival, 
most guidelines are rather cautious to recommend its routine use in ventilated patients [6]. A 
recent randomized clinical trial in three ICUs, however, again showed the preventive capacity 
of continuous lateral rotation therapy [26]. Rotation therapy over an arc of 90° was performed 
continuously in a specialized designed bed. Patients in the experimental group experienced 
significantly less VAP compared to the control group (11% vs. 23%; p=0.048). Also, rotation 
therapy led to shorter ventilation time and length of stay. The latter observation may be 
subject of an economic analysis in which the use of expensive kinetic beds are balanced with 
the gains originating from a reduced length of hospitalization. Anyway, in the existence of 
much cheaper and effective ways to prevent VAP the routine use of kinetic beds is probably 
doomed to remain a matter of controversy. 
 
Saline instillation prior to endotracheal suctioning 
Besides kinetic beds there is also renewed interest in saline instillation before tracheal 
suctioning. This practice may be beneficial because greater amounts of secretions may be 
removed, it stimulates coughing, and may decrease biofilm formation in the endotracheal tube 
[8]. On the other hand saline instillation may promote VAP development by dislodging more 
bacterial colonies from the tube resulting in contamination of the lower airways. In a recent 
study by Caruso et al. patients randomized to the saline group experienced less 
microbiologically confirmed VAP (10.8% vs. 23.5%; p=0.008) [27]. Given, however, the 
potential harm associated with saline instillation, and the specific subset of oncologic patients 
in this study, more data are needed to make a strong recommendation [8]. 
 
Multimodality chest physiotherapy 
Various combinations of chest physiotherapy have beneficial effects on arterial oxygenation, 
hemodynamic ventilator effects, and changes in total lung/thorax compliance. In a 
randomized study Pattanshetty and Gaude evaluated the value of multimodality chest 
physiotherapy in the prevention of VAP [28]. Patients in the control group received twice 
daily chest physiotherapy by manual hyperinflation and suctioning, while patients in the 
experimental group  received additional chest wall vibrations and patient positioning. Study 
outcomes showed more successful weaning (62% vs. 31%; p=0.007) and a greater reduction 
in clinical pulmonary infection scores in the study group (average scores reduction: 3.4 vs. 
1.9; p<0.001). From this observation the authors suggest a potential in terms of VAP 
prevention but – without questioning the value of chest physiotherapy for other indications – 
we believe it is much too hasty to make this conclusion. 
 
Oral hygiene 
Poor oral health is a risk factor for pneumonia in critically ill patients. Although oral rinse 
with chlorhexidine has generally accepted as an effective measure to reduce the risk of VAP, 
it remains unclear which concentration to use, what the exposure time should be, and how 
frequently it should be performed [29, 30]. Also the issue of teeth brushing remains 
controversial. Only one randomized controlled study evaluated the effect of dental brushing in 
mechanical ventilated ICU patients [31]. In this study twice daily electric tooth brushing 
combined with chlorhexidine-based oral rinse vs. oral rinse without dental brushing did not 
result in a reduction of the risk of either suspected VAP (odds ratio [OR] 0.78, 95%CI 0.36 to 
1.68) or documented VAP (OR 1.14, 95% CI 0.46 to 2.81). However, these results do not 
indicate futility of teeth brushing in intubated patients. While brushing teeth may not 
necessarily lead to reduced VAP rates, it contributes to the prevention of dental plaque, 
stomatitis, gingivitis, subgingivitis, and periodontitis. An additional problem is that oral care 
is perceived as a difficult and unpleasant task; moreover, most nurses give to understand they 
lack training and efficient equipment to care for the oral cavity [32]. Therefore, investments in 
training and appropriate equipment are pivotal. 
  
Care bundles to prevent VAP 
Especially in units with an already high standard in infection prevention, single preventive 
measures will generally insufficient to further decrease the rate of VAP. The concept of 
implementing a package of measures is therefore attractive as it is more likely to make a 
difference. A recent review stated that a care bundle is an effective method to prevent VAP 
[33]. However, the effect of care bundles is generally evaluated by means of before-after 
designs which are prone to bias, such as natural fluctuations in infection rates. This makes 
interpretation of the study results difficult. In addition, it seems important which items to 
include. Some preventive measures will be adopted more easy than others. Crucial is the 
willingness of the team to change their routine practice. In this regard, it is important to 
involve the whole team in the process of developing a care bundle.  
Rello et al. developed  care bundle based on a multi-criteria decision analysis [34]. In this way 
the a formalized methodology was used to end up with a set of preventive measures for which 
there exists a broad willingness to support its implementation. The selected items are showed 
in Table 1. Finally, as mentioned by Kollef, the work is not accomplished by implementing a 
care bundle [35]. Implementation of a care bundle should be accompanied by a surveillance 
program to closely monitor VAP rates. Adjustments must be made according to the 
occurrence rate of VAP, and the care bundle should be integrated in other quality 
improvement programs. 
 
Conclusion 
A wide range of measures to prevent VAP have been developed. Among them innovative 
endotracheal tubes to minimize micro-aspiration of subglottic secretions, cuff pressure control 
devices, aspects of oral hygiene and chest physiotherapy. While some of these measures are 
well established and generally accepted as effective in the prevention of VAP, some need 
additional confirmation. Besides the prevention measure as such, more attention must be 
given to aspects of team dynamics. Awareness and knowledge can be enhanced through 
targeted education. The implementation process can be facilitated by involving the team in the 
development of the quality improvement program.  
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Bullet points. 
 Implementation of care bundles is to be  preferred above single prevention measures. 
 Education is of key importance as it positively affect knowledge, awareness and 
attitude. 
 Intermittent subglottic secretions drainage, continuous lateral rotation therapy, and 
poly-urethane cuffed endotracheal tubes decrease the risk of pneumonia.  
 Endotracheal tubes with a tapered shaped cuff appear to better prevent fluid leakage.  
Table 1 – European care bundle developed for the prevention of ventilator-associated 
pneumonia [33].  
 
Note to editor: “original table” 
 
Preventive measure 
No ventilator circuit tube changes unless specifically indicated 
Strict hand hygiene practice with use of alcohol-based hand rub 
Appropriately educated and trained staff 
Sedation vacation and weaning protocol 
Oral care with use of chlorhexidine 
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